NNIT

Hiring quality verdict.

NNIT sits at the intersection of life sciences and regulated technology — its primary customer base is the global pharma and MedTech industry, and its competitive position depends on GxP-validated AI deployments and EU AI Act compliance frameworks that most generalist IT firms cannot build. Revenue declined 3.4% in 2025 as pharma clients delayed projects, but NNIT emerged from that reset leaner and with an accelerated AI agenda. For engineers who want to work at the boundary of clinical validation and production ML, NNIT offers a niche not widely available elsewhere in Copenhagen.